Evidence map›Paper›PMID 41301651›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Treatment Options for Critically Ill Patients with Infections Caused by Metallo-Beta-Lactamase-Producing

Konstantinos Mantzarlis, Vassilios Vazgiourakis, Dimitrios Papadopoulos, Asimina Valsamaki, Stelios Xitsas, Masumi Tanaka, Achilleas Chovas, Efstratios Manoulakas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Konstantinos MantzarlisDepartment of Critical Care, University Hospital of Larissa, School of Medicine, University of Thessaly, 41110 Larissa, Thessaly, Greece.ORCID 0000-0002-2453-5398
Vassilios VazgiourakisDepartment of Critical Care, University Hospital of Larissa, School of Medicine, University of Thessaly, 41110 Larissa, Thessaly, Greece.ORCID 0000-0002-6747-1961
Dimitrios PapadopoulosDepartment of Critical Care, General Hospital of Larissa, 41221 Larissa, Thessaly, Greece.ORCID 0000-0001-7778-4438
Asimina ValsamakiDepartment of Critical Care, University Hospital of Larissa, School of Medicine, University of Thessaly, 41110 Larissa, Thessaly, Greece.ORCID 0000-0001-8814-0371
Stelios XitsasDepartment of Microbiology, University Hospital of Larissa, School of Medicine, University of Thessaly, 41110 Larissa, Thessaly, Greece.ORCID 0000-0001-6865-6071
Masumi TanakaCritical Care Department, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK.ORCID 0000-0003-0499-4981
Achilleas ChovasDepartment of Critical Care, General Hospital of Larissa, 41221 Larissa, Thessaly, Greece.
Efstratios ManoulakasDepartment of Critical Care, University Hospital of Larissa, School of Medicine, University of Thessaly, 41110 Larissa, Thessaly, Greece.ORCID 0000-0003-1951-2105

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ceftazidime–avibactam + aztreonamcritically ill patientsdouble carbapenem therapyMBL-producing K. pneumoniaesurvival

Identifiers

PMID41301651
PMCPMC12649410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.